These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28417295)

  • 41. Pulmonary arterial hypertension induced by tyrosine kinase inhibitors.
    Weatherald J; Chaumais MC; Montani D
    Curr Opin Pulm Med; 2017 Sep; 23(5):392-397. PubMed ID: 28639957
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monocrotaline-induced pulmonary hypertension in Wistar rats.
    Rey M; Hess P; Clozel M
    Curr Protoc Pharmacol; 2009 Sep; Chapter 5():Unit 5.56. PubMed ID: 22294402
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pulmonary arterial hypertension: modern diagnostics and therapy--Part 1].
    Betkier-Lipińska K; Ryczek R; Kwasiborski P; Cwetsch A
    Pol Merkur Lekarski; 2013 Jun; 34(204):355-9. PubMed ID: 23882936
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pulmonary hypertension and ventilation during exercise: Role of the pre-capillary component.
    Caravita S; Faini A; Deboeck G; Bondue A; Naeije R; Parati G; Vachiéry JL
    J Heart Lung Transplant; 2017 Jul; 36(7):754-762. PubMed ID: 28131663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pulmonary artery acceleration time in identifying pulmonary hypertension patients with raised pulmonary vascular resistance.
    Tossavainen E; Söderberg S; Grönlund C; Gonzalez M; Henein MY; Lindqvist P
    Eur Heart J Cardiovasc Imaging; 2013 Sep; 14(9):890-7. PubMed ID: 23295626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spontaneously remitted pulmonary arterial hypertension associated with the herbal medicine "bofutsushosan".
    Sakurai Y; Tanabe N; Sekine A; Nishimura R; Jujo T; Kawasaki T; Sugiura T; Sakao S; Kasahara Y; Tatsumi K
    Intern Med; 2013; 52(13):1499-502. PubMed ID: 23812198
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases.
    Souza R; Humbert M; Sztrymf B; Jaïs X; Yaïci A; Le Pavec J; Parent F; Hervé P; Soubrier F; Sitbon O; Simonneau G
    Eur Respir J; 2008 Feb; 31(2):343-8. PubMed ID: 17959632
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An evidence-based approach to the management of pulmonary arterial hypertension.
    Archer SL; Michelakis ED
    Curr Opin Cardiol; 2006 Jul; 21(4):385-92. PubMed ID: 16755209
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serotonin transporter and serotonin receptors.
    Adnot S; Houssaini A; Abid S; Marcos E; Amsellem V
    Handb Exp Pharmacol; 2013; 218():365-80. PubMed ID: 24092348
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Primary pulmonary hypertension: follow-up of patients with and without anorectic drug intake.
    Mlczoch J; Probst P; Szeless S; Kaindl F
    Cor Vasa; 1980; 22(4):251-7. PubMed ID: 7449394
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hemodynamics of patients developing pulmonary arterial hypertension after shunt closure.
    D'Alto M; Romeo E; Argiento P; Correra A; Santoro G; Gaio G; Sarubbi B; Calabrò R; Russo MG
    Int J Cardiol; 2013 Oct; 168(4):3797-801. PubMed ID: 23850317
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value of acute vasodilator response in pulmonary arterial hypertension: beyond the "classic" responders.
    Halliday SJ; Hemnes AR; Robbins IM; Pugh ME; Zhao DX; Piana RN; Fong PP; Brittain EL
    J Heart Lung Transplant; 2015 Mar; 34(3):312-8. PubMed ID: 25577565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel technologies and devices for monitoring and treating pulmonary arterial hypertension.
    Khan SS; Rich JD
    Can J Cardiol; 2015 Apr; 31(4):478-88. PubMed ID: 25840097
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension.
    Mathai SC; Girgis RE; Fisher MR; Champion HC; Housten-Harris T; Zaiman A; Hassoun PM
    Eur Respir J; 2007 Mar; 29(3):469-75. PubMed ID: 17079256
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term follow-up of pulmonary hypertension in patients with and without anorectic drug intake.
    Loogen F; Worth H; Schwan G; Goeckenjan G; Lösse B; Horstkotte D
    Cor Vasa; 1985; 27(2-3):111-24. PubMed ID: 4028729
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Definitions and diagnosis of pulmonary hypertension].
    Hoeper MM; Bogaard HJ; Condliffe R; Frantz R; Khanna D; Kurzyna M; Langleben D; Manes A; Satoh T; Torres F; Wilkins MR; Badesch DB
    Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 1():55-66. PubMed ID: 25697034
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A review of pulmonary arterial hypertension: role of ambrisentan.
    Barst RJ
    Vasc Health Risk Manag; 2007; 3(1):11-22. PubMed ID: 17583171
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Pulmonary hypertension: definition, diagnostic and new classification].
    Seferian A; Simonneau G
    Presse Med; 2014 Sep; 43(9):935-44. PubMed ID: 25127985
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hemodynamics in pulmonary arterial hypertension: current and future perspectives.
    Saggar R; Sitbon O
    Am J Cardiol; 2012 Sep; 110(6 Suppl):9S-15S. PubMed ID: 22921033
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Review of the Ongoing Story of Appetite Suppressants, Serotonin Pathway, and Pulmonary Vascular Disease.
    Bazan IS; Fares WH
    Am J Cardiol; 2016 May; 117(10):1691-1696. PubMed ID: 27018933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.